Dr. Berman-Rosenzweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Woods Road
Suite 1121
Valhalla, NY 10595Phone+1 914-493-6160
Summary
- William Russell McCurdy Physician-in-Chief and Director of Pediatrics at Maria Fareri Children's Hospital of WMC Health, and Chair of the Department of Pediatrics at NY Medical College of Touro University. Professor of Pediatrics and Medicine at New York Medical College. Pulmonary Hypertension expert (Adults and Children). Former, Director of the Pulmonary Hypertension Comprehensive Care Center and CTEPH Program at Columbia University Medical Center - New York Presbyterian (4/2008 - 8/2024). I am also currently the Director of the Pediatric Pulmonary Hypertension Network (PPHNet) and Board member of Team PHenomenal Hope. Member, SLC Distinguished Advisory Committee for the PHA. I care for adults and children with all forms of Pulmonary Hypertension. I have a special interest in chronic thromboembolic pulmonary hypertension, pulmonary hypertension associated with congenital heart disease including the reverse Potts shunt and ECMO for bridging advanced pulmonary hypertension and right heart failure.
Education & Training
- University of MichiganBA, Psychology, with Distinction, 1985 - 2019
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Cardiology, 1996 - 1999
- New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 1993 - 1996
- Icahn School of Medicine at Mount SinaiClass of 1993
Certifications & Licensure
- NY State Medical License 1996 - 2025
- American Board of Pediatrics Pediatric Cardiology
- American Board of Internal Medicine Adult Congenital Heart Disease
Awards, Honors, & Recognition
- Board of Trustees (former member) Pulmonary Hypertension Association
- Board member Team PHenomenal Hope, 2023-2024
- Director PPHNet, 2022-2024
- Join now to see all
Clinical Trials
- The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting Start of enrollment: 2006 Sep 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Eisenmenger Quality Enhancement Research Initiative Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 339 citationsPaediatric pulmonary arterial hypertension : updates on definition, classification, diagnostics and managementErika B. Rosenzweig, Steven H. Abman, Ian Adatia, Maurice Beghetti, Damien Bonnet
The European Respiratory Journal. 2019-01-01 - 178 citationsHospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacityRoberto F. Machado, Robyn J. Barst, Nancy A. Yovetich, Kathryn L. Hassell, Gregory J. Kato
Blood. 2011-07-28 - 158 citationsAn Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell DiseaseElizabeth S. Klings, Roberto F. Machado, Robyn J. Barst, Claudia R. Morris, Kamal K. Mubarak
American Journal of Respiratory and Critical Care Medicine. 2014-03-15
Committees
- Scientific Board, World Symposium on Pulmonary Hypertension Association 2019 - 2024
- Chair, Scientific Leadership Council, PHA 2016 - 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: